Galapagos shows that the fittest can survive
Interviewee/Contributor
Piet Wigerinck and Walid Abi-Saab
Organisation
Galapagos NV
Research Directory
Oncology Review: New drugs target niche tumours, expand patient benefit
Interviewee/ContributorBruno PagliaraOrganisationOn-kòs Pharma ConsultingWHO embraces innovation in oncology
Interviewee/ContributorVictoria EnglishOrganisationMedNousEuropean biotechs narrowly ahead
Interviewee/ContributorWilliam EllingtonOrganisationMedNousExploiting enzymes from the Arctic Ocean
Interviewee/ContributorChristian JørgensenOrganisationBiotec Pharmacon ASATechnology for direct cell reprogramming
Interviewee/ContributorJulian GoughOrganisationMogrify LtdExploring new business models for antibiotics
Interviewee/ContributorHeather GrazOrganisationNeem Biotech LtdVivoryon Therapeutics tests Alzheimer's drug
Interviewee/ContributorUlrich DauerOrganisationVivoryon Therapeutics AGGut microbiota is new frontier in CNS research
Interviewee/ContributorPeter CharlishOrganisationMedNousTaking on the Alzheimer's conundrum
Interviewee/ContributorReisa SperlingOrganisationHarvard Medical School